Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
28 June 2021 | Story Lunga Luthuli | Photo Lunga Luthuli
South Campus: Social Responsibility Project team with Free State Department of Health nurses during the lunch of the campus’ COVID-19 pop-up vaccination site.

On Monday 27 September 2021, the University of the Free State, Provincial Department of Health and Department of Education launched a pop-up vaccination site at the South Campus bringing much-needed services closer to communities in the fight to end the COVID-19 pandemic.

Thandeka Mosholi, Head of Social Responsibility, Enterprise and Community Engagement, South Campus says, “We are next to the Mangaung community and bringing these services we encourage not only UFS staff and students but the surrounding communities to vaccinate for COVID-19. The institution and stakeholders are saying it is everyone’s responsibility for their health.”

She says, “If vaccination is recommended and we are told that it is safe, we encourage everyone including the youth to preserve our health and vaccinate.”

Representing the Department of Health, Papi Mokhele, Professional Pharmacist, says, “The initiative is aimed at reaching out to as many people to be vaccinated.”

He says, “At the moment the facility administers only the Pfizer vaccination and, as recommended by the National Government, we want to reach herd immunity – about 70% of the population – so that businesses, sporting facilities and many others can open and get our life back to normal.”

Other facilities the Department of Health has recently opened include the SABC Hoffman Square, Majakathata Taxi Rank, MUCCPP Health Centre in Phelindaba, Puma Garage in Bergman and Mangaung Outdoor Centre.

On partnering with the UFS, Mokhele says, “The COVID-19 vaccines have been put through clinical processes and quality assurance tests. They have also been approved by the South African Medicine Control Council and we call on the UFS community, especially students, to register and vaccinate.”

Coretha van den Heever, Teacher Trainer in the Social Responsibility Project, was recently vaccinated for the pandemic and says, “Let us protect ourselves and other people and not be the spreaders of the virus.”

She says, “People must make use of the facility; the UFS and government have brought the solution closer so that communities will not have to spend a lot of money travelling to get help.”

The vaccination centre will operate from Monday to Friday from 9:00 to 16:00.

News Archive

DNA sequencer launched at the UFS
2013-11-25

Dr Gansen Pillay, Deputy Chief Executive Officer of the National Research Foundation, explaining to the scholars what will be expected of them.

The University of the Free State (UFS) can now collect immensely valuable data on drug resistance in HIV/Aids and TB with the new DNA sequencer that was launched recently at the International workshop on HIV/AIDS and TB drug resistance at the Bloemfontein Campus.

The DNA sequencer will allow the Free State province to produce viral and bacterial genetic data to fight the local development of HIV/ Aids and TB drug resistance.

The HIV and TB epidemics have expanded very fast and South Africa now has the largest HIV and TB treatment programme in the world, with over 2 million patients on treatment. However, these successful treatment programmes are now being threatened by the appearance of drug resistance.

The Free State province has been at the forefront of fighting HIV drug resistance in South Africa and has one of the most advanced treatment programmes for the management of resistance strains in the country. In addition, researchers at the University of the Free State are leading partners in the Southern African Treatment and Resistance Network (SATuRN; www.bioafrica.net/saturn), a research network that has trained over 2 000 medical officers in the treatment of drug resistance strains.

The Department of Medical Microbiology and Virology in the Medical School at the UFS has partnered with the provincial department of health, the Medical Research Council (MRC) and the Delegation of the European Union to South Africa to fund a dedicated DNA sequencer machine that will be used to generate HIV and TB drug-resistance results. This new machine will enable cutting-edge research to take place, using the data in the province and, importantly, support patients with resistance strains to have access to advanced genotypic testing techniques.

“HIV drug resistance is a very serious problem in South Africa, and the recent advances in DNA testing technology allow clinicians in the province to access drug resistance testing, which enables them to manage patients appropriately who fail treatment, and use the results to cost-effectively extend and improve patients’ lives,” says Dr Cloete van Vuuren, Specialist in Infectious Diseases at the UFS’s Faculty of Health.

Dr Dominique Goedhals, pathologist from the Department of Medical Microbiology and Virology at the UFS, adds: “We have been looking forward to expanding our work with the clinicians and researchers, using DNA sequencing to shed light on the causes and consequences of drug resistance in urban and rural settings in the province.”

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept